Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats
Open Access
- 10 June 2005
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 116 (3), 464-470
- https://doi.org/10.1002/ijc.21082
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Recommended Guidelines for the Treatment of Cancer Treatment-Induced DiarrheaJournal of Clinical Oncology, 2004
- Amelioration of acute oral mucositis by Keratinocyte growth factor: fractionated irradiationInternational Journal of Radiation Oncology*Biology*Physics, 2002
- The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancerCancer Chemotherapy and Pharmacology, 2002
- Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humansGut, 2000
- Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated miceInternational Journal of Radiation Biology, 1999
- Irinotecan (CPT-11) and Characteristic Mucosal Changes in the Mouse Ileum and CecumJNCI Journal of the National Cancer Institute, 1995
- Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract.JCI Insight, 1994
- Relationship between Development of Diarrhea and the Concentration of SN‐38, an Active Metabolite of CPT‐11, in the Intestine and the Blood Plasma of Athymic Mice Following Intraperitoneal Administration of CPT‐11Japanese Journal of Cancer Research, 1993
- Quantitative histological study of enteropathy associated with HIV infection.Gut, 1990
- Peritz' F test: Basic program of a robust multiple comparison test for statistical analysis of all differences among group meansComputers in Biology and Medicine, 1984